Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-LITE: Peginterferon Lambda in HCV Genotype 1
NCT01309932Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2011
- Primary completion
- Jul 2014
- Modality
- Cytokines & Interferons
- Countries
- 9
01
Overview
A Phase 2 trial of peginterferon lambda-1a in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Mar 2011; status: completed.
02
Drugs
peginterferon lambda-1a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01309932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01309932.